14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 503 days ( -18.20 % )
Last Price $0.95 0 %
High/ Low $0.95 - $0.95 0%
Chg 7 Days N/A $0.95 $0.95
Chg 30 Days 0.406 % $0.95 $0.95
Chg 12 mos -18.47 % $1.17 $0.95
Trend - 3 mos -21.12 % Width: 31.55 %
Trend - 12 mos -11.43 % Width: 44.53 %
Pred. range - 3 mos $0.655 - $0.86 -31.38 % - -9.73 %
Pred. range - 12 mos $0.792 - $1.15 -16.94 % - 20.05 %
Short MA avg 3 mos Buy Apr 25, 2024 - 17 days
Long MA avg 3 mos Sell Apr 16, 2024 - 24 days
Short/Long MA avg 3 mos Sell Apr 16, 2024 - 24 days
Short MA avg 12 mos Buy May 14, 2024 - 4 days
Long MA avg 12 mos Sell Apr 16, 2024 - 24 days
Short/Long MA avg 12 mos Sell Apr 17, 2024 - 23 days
Pivot Short Sell May 16, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Buy No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Pharming Group N.V.

Pharming Group N.V. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment ... PHGUF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT